Form 13F-HR ORBIMED ADVISORS LLC For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/26/2024
May 17, 2021 4:23 PM EDT
The Securities and Exchange Commission has not necessarily reviewed
the information in this filing and has not determined if it is
accurate and complete.
The reader should not assume that the information is accurate
and complete.
|
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F
FORM 13F COVER PAGE
|
OMB APPROVAL |
OMB Number: |
3235-0006 |
Expires: |
July 31, 2015 |
Estimated average burden |
hours per response: |
23.8 |
|
|
Report for the Calendar Year or Quarter Ended: |
03-31-2021 |
Check here if Amendment |
|
Amendment Number: |
|
This Amendment (Check only one.): |
|
is a restatement. |
|
|
adds new holdings entries. |
Institutional Investment Manager Filing
this Report: |
Name: |
ORBIMED ADVISORS LLC |
Address: |
601 Lexington Avenue |
|
54th Floor |
|
|
|
New York
,
NY10022
|
Form 13F File Number: |
028-06774 |
The institutional investment manager filing this report and
the person by whom it is signed hereby represent that the person
signing the report is authorized to submit it, that all information
contained herein is true, correct and complete, and that it is
understood that all required items, statements, schedules, lists, and
tables, are considered integral parts of this form.
Person Signing this Report on Behalf of
Reporting Manager: |
Name: |
Sven H. Borho |
Title: |
Member |
Phone: |
212-739-6400 |
Signature, Place, and Date of Signing: |
/s/ Sven H. Borho |
New York
,
NY
|
05-17-2021 |
[Signature] |
[City, State] |
[Date] |
|
Report Type (Check only one.): |
X |
13F HOLDINGS REPORT. (Check here if all holdings of
this reporting manager are reported in this report.) |
|
13F NOTICE. (Check here if no holdings reported are in
this report, and all holdings are reported by other reporting
manager(s).) |
|
13F COMBINATION REPORT. (Check here if a portion of
the holdings for this reporting manager are reported in this
report and a portion are reported by other reporting manager(s).) |
Form 13F Summary Page |
|
Report Summary: |
|
Number of Other Included
Managers: |
1 |
|
|
|
Form 13F Information Table Entry Total: |
159 |
|
Form 13F Information Table Value Total: |
10,694,926 |
|
(thousands) |
|
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
|
|
|
Form 13F File Number |
Name |
|
028-10410 |
ORBIMED CAPITAL LLC |
List of Other Included
Managers: |
Provide a numbered list of the name(s) and Form 13F file number(s)
of all institutional investment managers with respect to which this
report is filed, other than the
manager filing this report.
|
[If there are no entries in this list, state “NONE” and omit the
column headings and list entries.]
|
|
No. |
Form 13F File Number |
Name |
|
1 |
028-10410 |
ORBIMED CAPITAL LLC |
The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
The reader should not assume that the information is
accurate and complete.
|
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F
FORM 13F INFORMATION TABLE
|
OMB APPROVAL |
OMB Number: |
3235-0006 |
Expires: |
July 31, 2015 |
Estimated average
burden |
hours per response:
|
23.8 |
|
|
COLUMN 1 |
COLUMN 2 |
COLUMN 3 |
COLUMN 4 |
COLUMN 5 |
COLUMN 6 |
COLUMN 7 |
COLUMN 8 |
|
|
|
VALUE |
SHRS OR |
SH/ |
PUT/ |
INVESTMENT |
OTHER |
VOTING AUTHORITY |
NAME OF ISSUER |
TITLE OF CLASS |
CUSIP |
(x$1000) |
PRN AMT |
PRN |
CALL |
DISCRETION |
MANAGER |
SOLE |
SHARED |
NONE |
89BIO INC |
COM |
282559103 |
88,313 |
3,729,442 |
SH |
|
SOLE |
|
3,729,442 |
0 |
0 |
9 METERS BIOPHARMA INC |
COM |
654405109 |
30,089 |
25,716,755 |
SH |
|
SOLE |
|
25,716,755 |
0 |
0 |
ABBVIE INC |
COM |
00287Y109 |
131,293 |
1,213,200 |
SH |
|
DFND |
|
228,100 |
0 |
985,100 |
ABCELLERA BIOLOGICS INC |
COM |
00288U106 |
278,498 |
8,200,768 |
SH |
|
SOLE |
|
8,200,768 |
0 |
0 |
ACHILLES THERAPEUTICS PLC |
SPONSORED ADS |
00449L102 |
26,229 |
1,584,845 |
SH |
|
DFND |
|
178,735 |
0 |
1,406,110 |
ACUTUS MED INC |
COM |
005111109 |
73,240 |
5,477,958 |
SH |
|
SOLE |
|
5,477,958 |
0 |
0 |
ADAGENE INC |
ADS |
005329107 |
4,936 |
275,000 |
SH |
|
SOLE |
|
275,000 |
0 |
0 |
ADICET BIO INC |
COM |
007002108 |
94,606 |
7,232,856 |
SH |
|
SOLE |
|
7,232,856 |
0 |
0 |
ADVERUM BIOTECHNOLOGIES INC |
COM |
00773U108 |
54,241 |
5,501,144 |
SH |
|
DFND |
|
655,897 |
0 |
4,845,247 |
AEGLEA BIOTHERAPEUTICS INC |
COM |
00773J103 |
31,803 |
4,015,524 |
SH |
|
SOLE |
|
4,015,524 |
0 |
0 |
AERPIO PHARMACEUTICALS INC |
COM |
00810B105 |
6,700 |
5,193,946 |
SH |
|
SOLE |
|
5,193,946 |
0 |
0 |
ALECTOR INC |
COM |
014442107 |
12,315 |
611,478 |
SH |
|
SOLE |
|
611,478 |
0 |
0 |
ALEXION PHARMACEUTICALS INC |
COM |
015351109 |
15,612 |
102,100 |
SH |
|
SOLE |
|
0 |
0 |
102,100 |
ALEXION PHARMACEUTICALS INC |
COM |
015351109 |
22,937 |
150,000 |
SH |
Call |
DFND |
|
42,500 |
0 |
107,500 |
ALIGNMENT HEALTHCARE INC |
COM |
01625V104 |
17,544 |
800,000 |
SH |
|
DFND |
|
124,500 |
0 |
675,500 |
ALPINE IMMUNE SCIENCES INC |
COM |
02083G100 |
32,552 |
3,070,955 |
SH |
|
SOLE |
|
3,070,955 |
0 |
0 |
ALX ONCOLOGY HLDGS INC |
COM |
00166B105 |
11,061 |
150,000 |
SH |
|
SOLE |
|
0 |
0 |
150,000 |
AMGEN INC |
COM |
031162100 |
22,766 |
91,500 |
SH |
|
SOLE |
|
0 |
0 |
91,500 |
ANTHEM INC |
COM |
036752103 |
102,875 |
286,600 |
SH |
|
DFND |
|
39,800 |
0 |
246,800 |
APPLIED THERAPEUTICS INC |
COM |
03828A101 |
42,337 |
2,257,387 |
SH |
|
DFND |
|
156,706 |
0 |
2,100,681 |
APTOSE BIOSCIENCES INC |
COM NEW |
03835T200 |
47,979 |
8,030,000 |
SH |
|
SOLE |
|
0 |
0 |
8,030,000 |
ARCTURUS THERAPEUTICS HLDGS |
COM |
03969T109 |
49,844 |
1,206,886 |
SH |
|
DFND |
|
159,626 |
0 |
1,047,260 |
ARCUTIS BIOTHERAPEUTICS INC |
COM |
03969K108 |
175,716 |
6,073,850 |
SH |
|
DFND |
|
4,267,564 |
0 |
1,806,286 |
ARYA SCIENCES ACQUISITION CO |
COM CL A |
G3166W106 |
680 |
49,375 |
SH |
|
DFND |
|
20,900 |
0 |
28,475 |
ASCENDIS PHARMA A/S |
SPONSORED ADR |
04351P101 |
65,105 |
505,159 |
SH |
|
DFND |
|
61,000 |
0 |
444,159 |
ASLAN PHARMACEUTICALS LTD |
ADS |
04522R101 |
8,442 |
2,520,000 |
SH |
|
SOLE |
|
0 |
0 |
2,520,000 |
AURINIA PHARMACEUTICALS INC |
COM |
05156V102 |
78,806 |
6,069,032 |
SH |
|
DFND |
|
585,300 |
0 |
5,483,732 |
AXSOME THERAPEUTICS INC |
COM |
05464T104 |
2,831 |
50,000 |
SH |
Put |
DFND |
|
18,000 |
0 |
32,000 |
BELLUS HEALTH INC NEW |
COM NEW |
07987C204 |
15,100 |
3,954,800 |
SH |
|
SOLE |
|
3,954,800 |
0 |
0 |
BIOGEN INC |
COM |
09062X103 |
22,940 |
82,000 |
SH |
|
SOLE |
|
0 |
0 |
82,000 |
BIOMX INC |
COM |
09090D103 |
16,472 |
2,313,489 |
SH |
|
SOLE |
|
2,313,489 |
0 |
0 |
BOSTON SCIENTIFIC CORP |
COM |
101137107 |
267,481 |
6,920,600 |
SH |
|
DFND |
|
939,400 |
0 |
5,981,200 |
BRISTOL-MYERS SQUIBB CO |
COM |
110122108 |
285,057 |
4,515,400 |
SH |
|
DFND |
|
569,100 |
0 |
3,946,300 |
BURNING ROCK BIOTECH LTD |
SPONSORED ADS |
12233L107 |
51,085 |
1,897,663 |
SH |
|
DFND |
|
201,999 |
0 |
1,695,664 |
CATALYST BIOSCIENCES INC |
COM NEW |
14888D208 |
10,678 |
2,118,600 |
SH |
|
SOLE |
|
0 |
0 |
2,118,600 |
CEL-SCI CORP |
COM PAR NEW |
150837607 |
1,521 |
100,000 |
SH |
Put |
DFND |
|
35,500 |
0 |
64,500 |
CHEMOMAB THERAPEUTICS LTD |
SPONSORED ADS |
16385C104 |
74,019 |
2,578,174 |
SH |
|
SOLE |
|
2,578,174 |
0 |
0 |
CHINOOK THERAPEUTICS INC |
COM |
16961L106 |
19,425 |
1,250,001 |
SH |
|
DFND |
|
250,000 |
0 |
1,000,001 |
COMPASS PATHWAYS PLC |
SPONSORED ADS |
20451W101 |
4,706 |
127,816 |
SH |
|
DFND |
|
38,816 |
0 |
89,000 |
CORVUS PHARMACEUTICALS INC |
COM |
221015100 |
24,804 |
8,053,298 |
SH |
|
SOLE |
|
8,053,298 |
0 |
0 |
CRINETICS PHARMACEUTICALS IN |
COM |
22663K107 |
42,075 |
2,753,567 |
SH |
|
SOLE |
|
2,753,567 |
0 |
0 |
CRISPR THERAPEUTICS AG |
NAMEN AKT |
H17182108 |
67,322 |
552,500 |
SH |
|
DFND |
|
47,500 |
0 |
505,000 |
CTI BIOPHARMA CORP |
COM |
12648L601 |
21,885 |
7,520,600 |
SH |
|
SOLE |
|
7,520,600 |
0 |
0 |
CULLINAN ONCOLOGY INC |
COM |
230031106 |
47,760 |
1,146,145 |
SH |
|
DFND |
|
959,245 |
0 |
186,900 |
CURIS INC |
COM NEW |
231269200 |
49,429 |
4,366,494 |
SH |
|
DFND |
|
195,900 |
0 |
4,170,594 |
DECIBEL THERAPEUTICS INC |
COM |
24343R106 |
56,177 |
4,945,192 |
SH |
|
DFND |
|
4,061,774 |
0 |
883,418 |
DECIPHERA PHARMACEUTICALS IN |
COM |
24344T101 |
61,920 |
1,380,900 |
SH |
|
DFND |
|
190,100 |
0 |
1,190,800 |
DEXCOM INC |
COM |
252131107 |
106,883 |
297,400 |
SH |
|
DFND |
|
37,000 |
0 |
260,400 |
DYNE THERAPEUTICS INC |
COM |
26818M108 |
5,436 |
350,000 |
SH |
|
SOLE |
|
0 |
0 |
350,000 |
EDGEWISE THERAPEUTICS INC |
COM |
28036F105 |
453,202 |
13,944,680 |
SH |
|
DFND |
|
13,679,055 |
0 |
265,625 |
EDWARDS LIFESCIENCES CORP |
COM |
28176E108 |
94,212 |
1,126,400 |
SH |
|
DFND |
|
151,600 |
0 |
974,800 |
FLEXION THERAPEUTICS INC |
COM |
33938J106 |
20,657 |
2,308,083 |
SH |
|
DFND |
|
84,100 |
0 |
2,223,983 |
FLUIDIGM CORP DEL |
COM |
34385P108 |
2,260 |
500,000 |
SH |
Call |
DFND |
|
175,500 |
0 |
324,500 |
FLUIDIGM CORP DEL |
COM |
34385P108 |
20,790 |
4,599,571 |
SH |
|
DFND |
|
484,800 |
0 |
4,114,771 |
FORTE BIOSCIENCES INC |
COM |
34962G109 |
5,472 |
159,664 |
SH |
|
DFND |
|
55,530 |
0 |
104,134 |
FUSION PHARMACEUTICALS INC |
COM |
36118A100 |
34,570 |
3,224,770 |
SH |
|
DFND |
|
2,930,670 |
0 |
294,100 |
GALAPAGOS NV |
SPON ADR |
36315X101 |
17,800 |
230,905 |
SH |
|
DFND |
|
25,700 |
0 |
205,205 |
GALECTO INC |
COM |
36322Q107 |
24,852 |
4,090,937 |
SH |
|
DFND |
|
3,803,255 |
0 |
287,682 |
GEMINI THERAPEUTICS INC |
COM |
36870G105 |
78,945 |
5,826,224 |
SH |
|
SOLE |
|
5,826,224 |
0 |
0 |
GILEAD SCIENCES INC |
COM |
375558103 |
18,588 |
287,600 |
SH |
|
SOLE |
|
0 |
0 |
287,600 |
GRACELL BIOTECHNOLOGIES INC |
SPONSORED ADS |
38406L103 |
121,427 |
7,884,870 |
SH |
|
DFND |
|
5,970,672 |
0 |
1,914,198 |
GRAYBUG VISION INC |
COM SHS |
38942Q103 |
23,107 |
4,163,347 |
SH |
|
SOLE |
|
4,163,347 |
0 |
0 |
GUARDANT HEALTH INC |
COM |
40131M109 |
149,200 |
977,400 |
SH |
|
DFND |
|
108,700 |
0 |
868,700 |
HAEMONETICS CORP MASS |
COM |
405024100 |
94,581 |
852,000 |
SH |
|
DFND |
|
90,500 |
0 |
761,500 |
HARPOON THERAPEUTICS INC |
COM |
41358P106 |
47,817 |
2,285,704 |
SH |
|
DFND |
|
1,020,704 |
0 |
1,265,000 |
HEALTH CATALYST INC |
COM |
42225T107 |
8,400 |
179,598 |
SH |
|
SOLE |
|
179,598 |
0 |
0 |
HEALTH SCIENCES ACQ CORP 2 |
ORD SHS |
G4411D109 |
5,595 |
500,000 |
SH |
|
DFND |
|
100,000 |
0 |
400,000 |
HORIZON THERAPEUTICS PUB L |
SHS |
G46188101 |
289,406 |
3,144,355 |
SH |
|
DFND |
|
357,500 |
0 |
2,786,855 |
HUMANA INC |
COM |
444859102 |
131,477 |
313,600 |
SH |
|
DFND |
|
48,100 |
0 |
265,500 |
I MAB |
SPONSORED ADS |
44975P103 |
900 |
18,565 |
SH |
|
DFND |
|
1,900 |
0 |
16,665 |
IKENA ONCOLOGY INC |
COM |
45175G108 |
82,884 |
2,933,941 |
SH |
|
DFND |
|
1,936,886 |
0 |
997,055 |
IKENA ONCOLOGY INC |
NONVOTING |
000000000 |
175,587 |
6,215,466 |
SH |
|
DFND |
|
5,586,311 |
0 |
629,155 |
IMARA INC |
COM |
45249V107 |
22,956 |
2,719,902 |
SH |
|
DFND |
|
2,532,402 |
0 |
187,500 |
IMMUNOGEN INC |
COM |
45253H101 |
73,968 |
9,131,822 |
SH |
|
DFND |
|
573,800 |
0 |
8,558,022 |
INFLARX NV |
COM |
N44821101 |
4,150 |
1,064,118 |
SH |
|
SOLE |
|
0 |
0 |
1,064,118 |
INNOVAGE HLDG CORP |
COM |
45784A104 |
5,158 |
200,000 |
SH |
|
SOLE |
|
0 |
0 |
200,000 |
INTELLIA THERAPEUTICS INC |
COM |
45826J105 |
5,818 |
72,500 |
SH |
|
SOLE |
|
0 |
0 |
72,500 |
INTUITIVE SURGICAL INC |
COM NEW |
46120E602 |
103,156 |
139,600 |
SH |
|
DFND |
|
20,800 |
0 |
118,800 |
IOVANCE BIOTHERAPEUTICS INC |
COM |
462260100 |
210,384 |
6,645,100 |
SH |
|
DFND |
|
1,337,800 |
0 |
5,307,300 |
JOUNCE THERAPEUTICS INC |
COM |
481116101 |
18,728 |
1,823,600 |
SH |
|
DFND |
|
335,900 |
0 |
1,487,700 |
KALA PHARMACEUTICALS INC |
COM |
483119103 |
36,834 |
5,465,030 |
SH |
|
DFND |
|
4,714,195 |
0 |
750,835 |
KEROS THERAPEUTICS INC |
COM |
492327101 |
103,368 |
1,679,417 |
SH |
|
DFND |
|
1,268,734 |
0 |
410,683 |
KINNATE BIOPHARMA INC |
COM |
49705R105 |
119,901 |
3,847,929 |
SH |
|
DFND |
|
3,397,929 |
0 |
450,000 |
LANDOS BIOPHARMA INC |
COM |
515069102 |
6,558 |
681,000 |
SH |
|
SOLE |
|
0 |
0 |
681,000 |
LARIMAR THERAPEUTICS INC |
COM |
517125100 |
9,018 |
617,245 |
SH |
|
DFND |
|
107,384 |
0 |
509,861 |
LOGICBIO THERAPEUTICS INC |
COM |
54142F102 |
61,638 |
8,466,783 |
SH |
|
DFND |
|
7,948,265 |
0 |
518,518 |
LONGBOARD PHARMACEUTICALS IN |
COM |
54300N103 |
4,914 |
300,000 |
SH |
|
SOLE |
|
0 |
0 |
300,000 |
MAGENTA THERAPEUTICS INC |
COM |
55910K108 |
11,237 |
949,048 |
SH |
|
SOLE |
|
0 |
0 |
949,048 |
MEIRAGTX HLDGS PLC |
COM |
G59665102 |
59,205 |
4,102,925 |
SH |
|
DFND |
|
133,500 |
0 |
3,969,425 |
MERCK & CO. INC |
COM |
58933Y105 |
287,731 |
3,732,400 |
SH |
|
DFND |
|
465,000 |
0 |
3,267,400 |
MEREO BIOPHARMA GROUP PLC |
ADS |
589492107 |
58,183 |
17,264,763 |
PRN |
|
DFND |
|
9,210,992 |
0 |
8,053,771 |
MERSANA THERAPEUTICS INC |
COM |
59045L106 |
30,621 |
1,892,500 |
SH |
|
DFND |
|
77,900 |
0 |
1,814,600 |
MILESTONE PHARMACEUTICALS IN |
COM |
59935V107 |
14,960 |
2,583,821 |
SH |
|
SOLE |
|
0 |
0 |
2,583,821 |
MIRATI THERAPEUTICS INC |
COM |
60468T105 |
209,192 |
1,221,200 |
SH |
|
DFND |
|
170,900 |
0 |
1,050,300 |
MOLINA HEALTHCARE INC |
COM |
60855R100 |
37,963 |
162,400 |
SH |
|
DFND |
|
20,600 |
0 |
141,800 |
NANOBIOTIX SA |
SPONSORED ADS |
63009J107 |
7,520 |
500,000 |
SH |
|
SOLE |
|
0 |
0 |
500,000 |
NANOSTRING TECHNOLOGIES INC |
COM |
63009R109 |
40,931 |
622,900 |
SH |
|
DFND |
|
62,900 |
0 |
560,000 |
NATERA INC |
COM |
632307104 |
222,972 |
2,195,900 |
SH |
|
DFND |
|
273,300 |
0 |
1,922,600 |
NEUROCRINE BIOSCIENCES INC |
COM |
64125C109 |
126,592 |
1,301,715 |
SH |
|
DFND |
|
137,470 |
0 |
1,164,245 |
NEXTCURE INC |
COM |
65343E108 |
27,137 |
2,711,013 |
SH |
|
SOLE |
|
2,711,013 |
0 |
0 |
NOVAVAX INC |
COM NEW |
670002401 |
28,254 |
155,833 |
SH |
|
DFND |
|
20,210 |
0 |
135,623 |
NURIX THERAPEUTICS INC |
COM |
67080M103 |
9,327 |
300,000 |
SH |
|
SOLE |
|
0 |
0 |
300,000 |
NUVATION BIO INC |
COM CL A |
67080N101 |
8,360 |
800,000 |
SH |
|
SOLE |
|
0 |
0 |
800,000 |
OAK STR HEALTH INC |
COM |
67181A107 |
52,479 |
967,000 |
SH |
|
DFND |
|
108,000 |
0 |
859,000 |
OLEMA PHARMACEUTICALS INC |
COM |
68062P106 |
21,770 |
656,126 |
SH |
|
DFND |
|
227,792 |
0 |
428,334 |
OLINK HLDG AB |
SPONSORED ADS |
680710100 |
10,800 |
300,000 |
SH |
|
SOLE |
|
0 |
0 |
300,000 |
ONCOCYTE CORP |
COM |
68235C107 |
10,899 |
2,100,000 |
SH |
|
SOLE |
|
0 |
0 |
2,100,000 |
ORIC PHARMACEUTICALS INC |
COM |
68622P109 |
57,271 |
2,337,574 |
SH |
|
DFND |
|
2,212,571 |
0 |
125,003 |
OTONOMY INC |
COM |
68906L105 |
8,288 |
3,250,000 |
SH |
|
DFND |
|
769,200 |
0 |
2,480,800 |
PANDION THERAPEUTICS INC |
COM |
698340106 |
31,720 |
528,229 |
SH |
|
SOLE |
|
528,229 |
0 |
0 |
PASSAGE BIO INC |
COM |
702712100 |
121,711 |
6,962,899 |
SH |
|
DFND |
|
5,947,323 |
0 |
1,015,576 |
PMV PHARMACEUTICALS INC |
COM |
69353Y103 |
241,098 |
7,330,423 |
SH |
|
DFND |
|
6,589,330 |
0 |
741,093 |
PRELUDE THERAPEUTICS INC |
COM |
74065P101 |
435,020 |
10,039,691 |
SH |
|
DFND |
|
9,250,191 |
0 |
789,500 |
PRELUDE THERAPEUTICS INC |
NONVOTING |
000000000 |
246,122 |
5,680,186 |
SH |
|
DFND |
|
5,596,886 |
0 |
83,300 |
PROGYNY INC |
COM |
74340E103 |
85,693 |
1,925,260 |
SH |
|
DFND |
|
200,900 |
0 |
1,724,360 |
PROMETHEUS BIOSCIENCES INC |
COM |
74349U108 |
4,565 |
250,000 |
SH |
|
SOLE |
|
0 |
0 |
250,000 |
PROTARA THERAPEUTICS INC |
COM STK |
74365U107 |
7,083 |
450,000 |
SH |
|
DFND |
|
60,000 |
0 |
390,000 |
PULMONX CORP |
COM |
745848101 |
5,718 |
125,000 |
SH |
|
SOLE |
|
0 |
0 |
125,000 |
PURPLE BIOTECH LTD |
SPONSORED ADS |
74638P109 |
130 |
31,418 |
SH |
|
SOLE |
|
31,418 |
0 |
0 |
RELAY THERAPEUTICS INC |
COM |
75943R102 |
12,100 |
350,000 |
SH |
|
SOLE |
|
0 |
0 |
350,000 |
REPARE THERAPEUTICS INC |
COM |
760273102 |
105,154 |
3,426,325 |
SH |
|
DFND |
|
3,276,325 |
0 |
150,000 |
SANA BIOTECHNOLOGY INC |
COM |
799566104 |
2,008 |
60,000 |
SH |
|
SOLE |
|
0 |
0 |
60,000 |
SAREPTA THERAPEUTICS INC |
COM |
803607100 |
14,927 |
200,278 |
SH |
|
DFND |
|
64,700 |
0 |
135,578 |
SCPHARMACEUTICALS INC |
COM |
810648105 |
31,901 |
4,797,148 |
SH |
|
SOLE |
|
4,797,148 |
0 |
0 |
SELECTA BIOSCIENCES INC |
COM |
816212104 |
1,535 |
339,169 |
SH |
|
SOLE |
|
339,169 |
0 |
0 |
SI BONE INC |
COM |
825704109 |
41,522 |
1,305,300 |
SH |
|
SOLE |
|
0 |
0 |
1,305,300 |
SIERRA ONCOLOGY INC |
COM NEW |
82640U404 |
25,454 |
1,477,320 |
SH |
|
DFND |
|
1,306,860 |
0 |
170,460 |
SIGNIFY HEALTH INC |
CL A COM |
82671G100 |
6,584 |
225,000 |
SH |
|
SOLE |
|
0 |
0 |
225,000 |
SILVER SPIKE ACQUISITION COR |
*W EXP 08/02/202 |
G8136L114 |
1,057 |
150,200 |
SH |
|
SOLE |
|
0 |
0 |
150,200 |
SILVER SPIKE ACQUISITION COR |
CL A SHS |
G8136L106 |
12,859 |
700,400 |
SH |
|
SOLE |
|
0 |
0 |
700,400 |
SILVERBACK THERAPEUTICS INC |
COM |
82835W108 |
381,365 |
8,740,887 |
SH |
|
DFND |
|
7,788,510 |
0 |
952,377 |
SINOVAC BIOTECH LTD |
SHS |
P8696W104 |
72,000 |
2,839,500 |
SH |
|
SOLE |
|
0 |
0 |
2,839,500 |
SPRINGWORKS THERAPEUTICS INC |
COM |
85205L107 |
455,127 |
6,186,307 |
SH |
|
SOLE |
|
6,186,307 |
0 |
0 |
STRONGBRIDGE BIOPHARMA PLC |
SHS USD |
G85347105 |
4,815 |
1,744,669 |
SH |
|
DFND |
|
251,200 |
0 |
1,493,469 |
STRYKER CORPORATION |
COM |
863667101 |
82,184 |
337,400 |
SH |
|
DFND |
|
53,200 |
0 |
284,200 |
SUTRO BIOPHARMA INC |
COM |
869367102 |
7,966 |
350,000 |
SH |
|
SOLE |
|
0 |
0 |
350,000 |
SYNLOGIC INC |
COM |
87166L100 |
7,267 |
2,029,996 |
SH |
|
SOLE |
|
2,029,996 |
0 |
0 |
SYROS PHARMACEUTICALS INC |
COM |
87184Q107 |
13,745 |
1,837,500 |
SH |
|
SOLE |
|
0 |
0 |
1,837,500 |
TCR2 THERAPEUTICS INC |
COM |
87808K106 |
5,504 |
249,279 |
SH |
|
SOLE |
|
0 |
0 |
249,279 |
TELA BIO INC |
COM |
872381108 |
45,110 |
3,027,542 |
SH |
|
SOLE |
|
3,027,542 |
0 |
0 |
TERNS PHARMACEUTICALS INC |
COM |
880881107 |
83,406 |
3,791,204 |
SH |
|
SOLE |
|
3,791,204 |
0 |
0 |
THERAVANCE BIOPHARMA INC |
COM |
G8807B106 |
126,932 |
6,219,110 |
SH |
|
DFND |
|
674,898 |
0 |
5,544,212 |
THERMO FISHER SCIENTIFIC INC |
COM |
883556102 |
50,339 |
110,300 |
SH |
|
DFND |
|
16,800 |
0 |
93,500 |
TRAVERE THERAPEUTICS INC |
COM |
89422G107 |
13,187 |
528,100 |
SH |
|
DFND |
|
64,700 |
0 |
463,400 |
TRICIDA INC |
COM |
89610F101 |
50,860 |
9,614,280 |
SH |
|
SOLE |
|
9,614,280 |
0 |
0 |
TRILLIUM THERAPEUTICS INC |
COM NEW |
89620X506 |
18 |
1,700 |
SH |
Call |
DFND |
|
700 |
0 |
1,000 |
TRILLIUM THERAPEUTICS INC |
COM NEW |
89620X506 |
33,994 |
3,165,200 |
SH |
|
DFND |
|
206,900 |
0 |
2,958,300 |
TURNING POINT THERAPEUTICS I |
COM |
90041T108 |
223,358 |
2,361,327 |
SH |
|
DFND |
|
1,743,950 |
0 |
617,377 |
UNIQURE NV |
SHS |
N90064101 |
32,648 |
969,079 |
SH |
|
DFND |
|
138,100 |
0 |
830,979 |
UNITEDHEALTH GROUP INC |
COM |
91324P102 |
149,944 |
403,000 |
SH |
|
DFND |
|
56,500 |
0 |
346,500 |
VAXCYTE INC |
COM |
92243G108 |
12,813 |
648,774 |
SH |
|
SOLE |
|
0 |
0 |
648,774 |
VERONA PHARMA PLC |
SPONSORED ADS |
925050106 |
47,609 |
5,694,841 |
SH |
|
DFND |
|
5,028,174 |
0 |
666,667 |
VERRICA PHARMACEUTICALS INC |
COM |
92511W108 |
22,418 |
1,479,733 |
SH |
|
SOLE |
|
1,479,733 |
0 |
0 |
VERTEX PHARMACEUTICALS INC |
COM |
92532F100 |
244,094 |
1,135,900 |
SH |
|
DFND |
|
136,200 |
0 |
999,700 |
VISTAGEN THERAPEUTICS INC |
COM NEW |
92840H202 |
18,327 |
8,604,000 |
SH |
|
DFND |
|
979,000 |
0 |
7,625,000 |
VOR BIOPHARMA INC |
COM |
929033108 |
35,917 |
833,333 |
SH |
|
SOLE |
|
0 |
0 |
833,333 |
X4 PHARMACEUTICALS INC |
COM |
98420X103 |
11,829 |
1,373,849 |
SH |
|
SOLE |
|
1,373,849 |
0 |
0 |
XENON PHARMACEUTICALS INC |
COM |
98420N105 |
44,713 |
2,497,917 |
SH |
|
DFND |
|
786,612 |
0 |
1,711,305 |
XTANT MED HLDGS INC |
COM NEW |
98420P308 |
171,981 |
72,873,494 |
SH |
|
SOLE |
|
72,873,494 |
0 |
0 |